Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse
| Image |  |
|---|---|
| Description | scientific article published on 28 May 2020 |
| Author/s |
author: Thomas Skripuletz |
| Publication date | May 28, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |